发明名称 ALBUMIN VARIANTS
摘要 The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
申请公布号 US2014234311(A1) 申请公布日期 2014.08.21
申请号 US201414262244 申请日期 2014.04.25
申请人 NOVOZYMES BIOPHARMA DK A/S 发明人 Sleep Darrell;Plumridge Andrew;Cameron Jason;Sandlie Inger;Andersen Jan Terje;Friis Esben Peter
分类号 C07K14/765;A61K45/06;A61K47/48 主分类号 C07K14/765
代理机构 代理人
主权项 1. A Method for preparing a variant of albumin, fragments thereof or fusion polypeptide comprising said variant albumin or fragment thereof, comprising following steps: a. Providing a nucleic acid encoding a parent albumin having at least 80% sequence identity to SEQ ID NO: 2; b. Modifying the sequence of step a., to encode a variant albumin, fragments thereof or fusion polypeptide comprising said variant albumin or fragment thereof having one or more substitutions corresponding to the substitutions in SEQ ID NO: 2 selected among: Q417A,C,D,E,F,G,H,I,K,L,M,N,P, R,S,T,V,W,Y;H440A,C,D,E,F,G, I,K,L,M,N,P,Q,R,S,T,V,W,Y;A490C,D,E, F,G,H,I,K,L,M,N,P, R,S,T,V,W,YE492A,C,D,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;V493A,C,D,E,F,G,H,I,K,L,M,N,P,Q,R,S,T.W,Y:D494A,C,E,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;E495A,C,D,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;T496A,C,D,E,F,G,H,I,K,L,M,N,P,Q,R,S,V,W,Y;P499A,C,D,E,F,G,H,I,K,L,M,N, Q,R,S,T,V,W,Y;K500A,C,D,E,F,G,H,I, ,L,M,N, Q,R,S,T,V,W,Y;E501A,C,D,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;N503A,C,D,E,F,G,H,I,K,L,M, P,Q,R,S,T,V,W,Y;A504C,D,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;E505A,C,D,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;T506A,C,D,F,G,H,I,K,L,M,N,P,Q,R,S, V,W,Y;H510A,C,D,F,G,I,K,L,M,N,P,Q,R,S,T,V,W,Y;H535A,C,D,F,G, I,K,L,M,N,P,Q,R,S,T,V,W,Y;K536A,C,D,E,F,G,H,I, L,M,N,P,Q,R,S,T,V,W,Y;P537A,C,D,E,F,G,H,I,K,L,M,N, Q,R,S,T,V,W,Y;K538A,C,D,E,F,G,H,I, L,M,N,P,Q,R,S,T,V,W,Y;T540A,C,D,E,F,G,H,I, L,M,N,P,Q,R,S, ,V,W,Y;K541A,C,D,E,F,G,H,I, L,M,N,P,Q,R,S,T,V,W,Y;E542A,C,D,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;D550A,C,E,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;K573A,C,D,E,F,G,H,I, L,M,N,P,Q,R,S,T,V,W,Y;K574A,C,D,E,F,G,H,I, L,M,N,P,Q,R,S,T,V,W,Y;Q580A,C,D,E,F,G,H,I, K, L,M,N,P,R,S,T,V,W,Y;A581C,D,E,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y;A582C,D,E,F,G,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y; orG584A,C,D,E,F,H,I,K,L,M,N,P,Q,R,S,T,V,W,Y; c. Introducing the modified sequence of step b., in a suitable host cell; d. Growing the cells in a suitable growth medium under condition leading to expression of the variant of albumin, fragments thereof or fusion polypeptide comprising said variant albumin or fragment thereof; and e. Recovering the variant of albumin, fragments thereof or fusion polypeptide comprising said variant albumin or fragment thereof from the growth medium; wherein the variant of albumin, fragments thereof or fusion polypeptide comprising said variant albumin or fragment thereof, has an altered plasma half-life compared with the parent albumin, fragments thereof or fusion polypeptide comprising said variant albumin or fragment thereof.
地址 Bagsvaerd DK